Facebook
Twitter
LinkedIn
ForwardStem Cell Transplant Course Fall 2024
Target Audience
The course is designed for registered nurses and other healthcare professionals involved in caring for patients undergoing stem cell transplant. Six months to one year of oncology experience and the completion of the Foundations to Practice Series (Pathophysiology of Cancer, Cancer Treatment Modalities, and the Immune System; Overview of Solid Tumors; Symptom Management of Patients with Cancer; Oncology Emergencies and Advanced Cancer Care Issues; and Hematological Malignancies, and Antineoplastic Therapy and Immunotherapy Course or other introductory cancer courses are strongly recommended.
Learning Objectives
The learner will be able to:
- Discuss the role of stem cell transplant in cancer and other diseases.
- Compare and contrast the role of autologous, allogeneic, haploidentical, and cord blood transplant in treating hematological malignancies.
- Understand preparative regimen chemotherapy and what preparative regimen is indicated based on disease and other comorbidities.
- Understand the transfusion needs surrounding patients who need or receive a stem cell transplant.
- Describe appropriate interventions for the management of transplant associated complications including acute and chronic graft verse host disease, infection, and organ toxicities.
- Describe the process of pre transplant evaluation, mobilization, cell collection, cell infusion, and troubleshooting infusion related complications for transplant patients and donors.
- Understand HLA typing and donor selection for allogeneic and haploidentical transplants.
- Understand the purpose and importance of immunosuppression in the stem cell transplant population.
- Identify the role of rehabilitation resources in patients undergoing stem cell transplant.
- Understand the short term and long term follow up requirements and role of survivorship care planning, including patient education across the transplant continuum of care.
- Recall the clinical background of chimeric antigen receptor modified T-cells and the diseases indicated for this type of treatment.
- Discuss the outpatient management of a stem cell transplant patient.
- Recall the nursing care considerations of a patient receiving CAR T-cell therapy.
Additional Information
| Attachment | Size |
|---|---|
 SCT Activity Information Sheet Fall 2024.pdf | 159.14 KB |
| Kriner, Jaime 24-25.pdf | 305.66 KB |
| OConnor COI 2025.pdf | 439.22 KB |
Schedule: Wednesday, November 6, 2024
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule: Wednesday, November 13, 2024
|
Melissa Bastacky, PharmD, BCOP
Oncology Clinical Pharmacist
UPMC Shadyside
Amanda Blasko, BSN, RN
Oncology Clinical Coordinator
UPMC Hillman Cancer Center
Abigail Bollinger, PA-C
Physician Assistant
Supervisor Inpatient BMT
UPMC Hillman Cancer Center
Ashur-Dee Brown, MSN, RN, BMTCN
Program Manager
Cellular Therapy
UPMC Hillman Cancer Center
Sawa Ito, MD, PhD
Assistant Professor
Hematopoietic Stem Cell Transplant and Cell Therapy
Department of Medicine
University of Pittsburgh
Shannon Joy, CRNP
Nurse Practitioner
Palliative Care
Inpatient Consult Service
UPMC Shadyside
Erin Kerr, PT, DPT, GCS
Supervisor, Rehab Service, Oncology
University of Pittsburgh Adjunct Professor,
UPMC Shadyside
Wendy Lucas, MSN, RN, CCRN, CCNS, BMTCN
Advanced Clinical Education Specialist
UPMC Shadyside Hospital
Megan Marmol, BSN, RN
Sr. Professional Staff Nurse
UPMC Shadyside 6 West
Nichole Miller, PA-C
Physician Assistant
Stem Cell Transplant Service
University of Pittsburgh Physicians
Jennifer Minnier, PA-C
Physician Assistant
Stem Cell Transplant Service
University of Pittsburgh Physicians
Lynne O’Connor MSN, RN, OCN
Advanced Clinical Education Specialist
Manager, Professional and Patient Education
UPMC Hillman Cancer Center
Melissa Potter, MSW, LCSW, OSW-C, Clinical Social Worker
Lemieux Center for Blood Cancers
UPMC Hillman Cancer Center
Heather Poole, CRNP
Hematology Oncology
Inpatient BMT
UPMC Hillman Cancer Center and
UPMC Shadyside
Brittni Prosdocimo, MSN, RN, BMTCN
Director - Regulatory, Safety, Professional and Patient Education
Medical Oncology
UPMC Hillman Cancer Center
Alison Sehgal, MD, MS
Clinical Assistant Professor of Medicine
University of Pittsburgh Medical Center
UPMC Hillman Cancer Center
Darrell Triulzi, MD
Professor of Pathology
University of Pittsburgh
Medical Director the Institute for Transfusion Medicine
Jackie Wojton, BSN, RN, OCN
Clinician, 6 West
UPMC Shadyside
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours.
To receive 13 Contact Hours, the learner must sign in attendance each day, attend both days of the course virtually via TEAMS, and complete the activity evaluation.
Available Credit
- 13.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 13.00 APA
- 13.00 Attendance